Cat Umbilical Cord-derived Mesenchymal Stem Cells – Female


UC-MSCs derived from the umbilical cord tissue of a neonatal (day 0) female cat

1 x 106 cells

Please see our statement on why passage numbers can be misleading.

Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are multipotent stem cells with a high capacity for self-renewal. Umbilical cord stem cells can develop into specialized cells of the body such as chondrocytes, osteoblasts, and adipocytes, and their easy accessibility, exceptional genomic stability, and capacity for tissue repair with few immunological and ethical issues make them a favorable cell type for experimental and clinical use. Stem cells from umbilical cord have advantages over traditional sources of MSCs, including ease of collection, faster self-renewal, longer multipotency, and additional immunosuppressive properties, making them potentially beneficial in regenerative medicine and tissue engineering.

Feline umbilical cord-derived MSCs were isolated from the umbilical cord tissue of a neonatal (day 0) female domestic shorthair cat. The cells are cultured, passaged for purity, cryopreserved, and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Feline umbilical cord stem cells are characterized by flow cytometry for CD90, CD105, CD44, CD31, and CD45. Cells are assured to further culture using the protocol provided by JangoCell.

Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are also known as: UCMSCs, umbilical cord-derived mesenchymal stromal cells, umbilical cord medicinal signaling cells, umbilical cord stem cells, perinatal stem cells, umbilical cord-derived MSCs, umbilical cord mesenchymal stem cells, umbilical cord mesenchymal stromal cells.


Additional information






JangoCell Statement on Passage Number

While passage number is the de facto metric used for determining cell proliferation capacity, the actual capacity is dependent upon the total number of cell divisions (or population doubling number (PDN)) that a particular cell type can undergo. This can be illustrated with a simple example. Since stem cells are typically passaged upon reaching confluence, cells grown at low confluence in a flask or in a large vessel such as a bioreactor (large surface area to cell number) will require many more doublings to reach confluence before they are ‘passaged’ than cells seeded at high confluence. This can result in low passage numbers, but a cell population with more limited capacity for further cell division. Therefore, passage number is not the most reliable means of determining future cell proliferation capacity after purchase.

For these reasons, and to provide transparency concerning our cell products, JangoCell will express future cell division capacity, or the number of times that our cells will be able to divide and double in number after purchase (after thaw), in terms of population doubling number (PDN). We will express the current cell division number, or the number of times that our cells have already divided and doubled in number before cryopreservation, in terms of population doubling level (PDL). JangoCell’s primary stem cells when plated at ~20% confluency will display a PDN between 30-40 when cultured using the protocol recommended by JangoCell for each specific cell type.

Please see our page on passage number under Technical Resources for more information.

Catalog Number UC-MSC-CDF-05
Lot Number Included with shipment
Country of Manufacture USA
Quantity 1 x 106 cells/vial
Storage Immediately transfer cells from dry ice to liquid nitrogen upon arrival.
Shipping Info Dry ice; Overnight shipping
Also Known As UCMSCs, umbilical cord-derived mesenchymal stromal cells, umbilical cord medicinal signaling cells, umbilical cord stem cells, perinatal stem cells, umbilical cord-derived MSCs, umbilical cord mesenchymal stem cells, umbilical cord mesenchymal stromal cells.
Product Use This product is for research use only. It is not approved for use in humans, animals, or for diagnostic procedures.
References Zhai ZH, Li J, You Z, Cai Y, Yang J, An J, Zhao DP, Wang HJ, Dou MM, Du R and Qin J. Feline umbilical cord-derived mesenchymal stem cells: isolation, identification, and antioxidative stress role through NF-κB signaling pathway. Frontiers in Veterinary Science. 2023; 10:1203012. doi: 10.3389/fvets.2023.1203012.

Parys M, Kruger JM and Yuzbasiyan-Gurkan V. Evaluation of immunomodulatory properties of feline mesenchymal stem cells. Stem Cells and Development. 2017; 26(10):776-785. doi: 10.1089/scd.2016.0041.

Corrao S, La Rocca G, Lo lacono M, Corsello T, Farina F and Anzalone R. Umbilical cord revisited: from Wharton’s jelly myofibroblasts to mesenchymal stem cells. Histology and Histopathology. 2013; 28(10):1235-1244. doi: 10.14670/HH-28.1235. Epub 2013 Apr 18.

Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM, Kim WH and Kweon OK. Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton’s jelly for treating bone defects. Journal of Veterinary Science. 2012; 13(3):299-310. doi: 10.4142/jvs.2012.13.3.299. Epub 2012 Sep 20.

Contact us for the technical documents on this product.

This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the JangoCell product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the JangoCell product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided ‘AS IS’ with no representations or warranties whatsoever except as expressly set forth herein and in no event shall JangoCell, its parent company, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer’s use of the product. Any proposed commercial use is prohibited without a license from JangoCell.

Please see the Terms and Conditions of Sale for further details regarding the use of this product at

Does your published paper include JangoCell products?

If you publish a paper that includes any of our products, tell us and we will reward you with ONE Free JangoCell product.

That’s right – get 100% off a single JangoCell branded item in our store. Simply contact us and we’ll supply you with a coupon code.

Subscribe to Our Newsletter
Be the first to know about our latest products, specials, and research findings.